Consensus DermTech, Inc.

Equities

DMTK

US24984K1051

Market Closed - OTC Markets Other stock markets 03:57:54 2024-07-09 pm EDT			5-day change	1st Jan Change
0.062 ^USD	-3.12%		-31.11%	-96.46%

Jun. 26	DermTech, Inc.(NasdaqCM:DMTK) dropped from NASDAQ Composite Index	CI
Jun. 24	DermTech, Inc.(NasdaqCM:DMTK) dropped from S&P TMI Index	CI

Evolution of the average Target Price on DermTech, Inc.

Price target over the last 5 years

History of analyst recommendation changes

07882b2c0db6.iwGVkbJO7eZBgKJFO2b5dkKWL_4IQN91zlf7D50RGwU.u0rspoYfqbMxy-gjbS2_HRj5a4ZAM6Yzq2OcSOx1WXGmdNDL9iirtzm1wQ~63823dff6d51f6132c7ceef40fd5656c

Analyst Recommendations on DermTech, Inc.

Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	Apr. 19	MT
BTIG Downgrades DermTech to Neutral From Buy	Apr. 19	MT
BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	Mar. 07	MT
Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	Mar. 05	MT
BTIG Adjusts Price Target on DermTech to $5 From $6, Maintains Buy Rating	23-08-07	MT
Stephens Adjusts Price Target on DermTech to $5 From $16, Maintains Overweight Rating	22-11-09	MT
BTIG Adjusts Price Target on DermTech to $6 From $15, Maintains Buy Rating	22-11-08	MT
William Blair Downgrades DermTech to Market Perform From Outperform	22-11-04	MT
Oppenheimer Adjusts DermTech Price Target to $13 From $23, Maintains Outperform Rating	22-11-04	MT
Oppenheimer Adjusts DermTech's Price Target to $23 From $48, Maintains Outperform Rating	22-08-17	MT
BTIG Adjusts DermTech's Price Target to $15 From $19, Reiterates Buy Rating	22-08-15	MT
Craig-Hallum Adjusts DermTech's Price Target to $18 from $37, Maintains Buy Rating	22-08-09	MT
Oppenheimer Adjusts DermTech Price Target to $48 From $58, Maintains Outperform Rating	22-03-02	MT
Stephens Initiates DermTech With Overweight Rating, $26 Price Target	22-01-07	MT
Stephens Starts DermTech at Overweight	22-01-07	MT
BTIG Adjusts DermTech's Price Target to $48 From $53, Reiterates Buy Rating	21-11-22	MT
DERMTECH : BTIG Initiates DermTech at Buy With $53 Price Target	21-05-03	MT
DERMTECH : Oppenheimer Adjusts DermTech PT to $58 From $53 Following In Line Q4 Results, Maintains Outperform	21-03-05	MT
DERMTECH : Craig Hallum Adjusts DermTech PT to $70 From $49, Maintains Buy Rating	21-03-05	MT
DERMTECH : Oppenheimer Starts DermTech at Outperform With $53 Price Target	21-01-22	MT